牛磺酸上调基因1(TUG1)对肝纤维化的作用及其机制*

doi:10.12047/j.cjap.6139.2021.094

摘要/Abstract

摘要： 目的:探讨牛磺酸上调基因1(TUG1)在肝纤维化中的作用机制。方法:按照文献建立TGF-β1(5 ng/ml)刺激的活化肝星状细胞模型和经典的1%DMN(1 ml/kg/d)致大鼠肝纤维化模型,将肝纤维化大鼠和活化肝星状细胞(HSC)均分为模型对照组、阴性对照组(沉默TUG1阴性对照)、siRNA干扰组(TUG1基因沉默组)。实验结束后利用苏木精-伊红(HE)染色检测大鼠肝脏组织病理变化;采用逆转录-聚合酶链反应(RT-PCR)法、蛋白免疫印记(Western blot)分别测定大鼠肝组织及活化肝星状细胞中α-平滑肌肌动蛋白(α-SMA)、TUG1、I型胶原蛋白(collagenI)、基质金属蛋白酶-2(MMP-2)、金属蛋白酶组织抑制因子(TIMP-1)、Smad2、Smad3表达水平。结果:肝组织病理学检查显示,沉默TUG1能够明显缓解肝脏纤维化病理改变,Western blot结果显示,沉默TUG1能够显著降低大鼠肝组织和活化肝星状细胞中TUG1、α-SMA、collagenI、MMP-2、TIMP-1、Smad2、Smad3基因与蛋白表达水平(P＜0.05)。与模型对照组相比,阴性对照组的TUG1、α-SMA的蛋白与基因水平明显升高(P＜0.05)。与模型对照组和阴性对照组相比,siRNA干扰组中TUG1, α-SMA, collagenI, MMP-2, TIMP-1, Smad2 and Smad3的蛋白和基因水平显著降低(P＜0.05),而在模型对照组和阴性对照组中TUG1, α-SMA, collagenI, MMP-2, TIMP-1, Smad2 and Smad3的蛋白和基因表达水平之间差异无显著性。结论:TUG1在肝纤维化组织和活化的肝星状细胞中显著上调,沉默TUG1可能通过抑制转化生长因子-β1(TGF-β1)/Smad信号通路改善1%DMN致大鼠肝纤维化病理损伤,降低活化肝星状细胞中纤维化相关蛋白水平,发挥抗肝纤维化的作用。

关键词: 肝纤维化, 肝星状细胞, 大鼠, 牛磺酸上调基因1, 转染

Abstract: Objective: To investigate the effects and mechanisms of taurine up-regulated gene 1 (TUG1) in hepatic fibrosis. Methods: According to the literature, the classic hepatic fibrosis model of rats induced by 1%DMN(1ml/kg/d) was established. The rats with hepatic fibrosis and activated hepatic stellate cells (HSC) were divided into model control group, negative control group (transfected with siRNA negative control), siRNA interference group (transfected with TUG1). At the end of the experiment, hematoxylin eosin (HE) staining was used to detect the pathological changes of liver tissue; reverse transcription polymerase chain reaction (RT-PCR) and Western blot were used to determine the expression levels of α-smooth muscle actin (α-SMA), TUG1, collagen I, matrix metalloproteinase-2 (MMP-2), tissue inhibitor of metalloproteinase-1 (TIMP-1), Smad2 and Smad3 in rat liver tissue and activated hepatic stellate cells. Results: Compared with the model control group, the protein and gene levels of TUG1 and α-SMA in the negative control group were increased significantly(P＜0.05). The protein and gene levels of TUG1, α-SMA, collagen I, MMP-2, TIMP-1, Smad2 and Smad3 in the liver tissue and activated hepatic stellate cells in the siRNA interference group were decreased (P＜0.05) while compared with the blank control group and the negative control group. There were no significant differences in the levels of TUG1, α-SMA, collagen I, MMP-2, TIMP-1, Smad2 and Smad3 in the liver tissue and activated hepatic stellate cells between the control group and the negative control group (P＞0.05). Conclusion: TUG1 level is elevated in hepatic fibrosis tissue and activated hepatic stellate cells. Silencing TUG1 may improve the pathological damage of hepatic fibrosis induced by 1% DMN by inhibiting the transforming growth factor(TGF-β1)/ Smad signaling pathway.

Key words: liver fibrosis, hepatic stellate cells, rats, taurine up-regulated gene 1, transfection

中图分类号:

R575

朱海东, 吕长坤, 马菲菲. 牛磺酸上调基因1(TUG1)对肝纤维化的作用及其机制^*[J]. 中国应用生理学杂志, 2021, 37(6): 616-621.

ZHU Hai-dong, LYU Chang-kun, MA Fei-fei. Effects of TUG1 on hepatic fibrosis and its mechanism[J]. CJAP, 2021, 37(6): 616-621.

参考文献

[1] Altamirano-Barrera A, Barranco-Fragoso B, Méndez-Sánchez N. Management strategies for liverfibrosis[J]. Ann Hepatol, 2017, 16(1): 48-56.
[2] Wan Y, Meng F, Wu N, et al. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells[J]. Hepatology, 2017, 66(2): 528-541.
[3] Huang Y, Deng X, Liang J. Modulation of hepatic stellate cells and reversibility of hepatic fibrosis[J]. Exp Cell Res, 2017, 352(2): 420-426.
[4] Fu N, Niu X, Wang Y, et al. Role of LncRNA-activated by transforming growth factor beta in the progression of hepatitis C virus-related liver fibrosis[J]. Discov Med, 2016, 22(119): 29-42.
[5] Zhu Y, Feng Z, Jian Z, et al. Long noncoding RNA TUG1 promotes cardiac fibroblast transformation to myofibroblasts via miR29c in chronic hypoxia[J]. Mol Med Rep, 2018, 18(3): 3451-3460.
[6] Zhang Y, Huang JC, CaiKT, et al. Long noncoding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRTPCR and metaanalysis of 393 cases[J]. Int J Oncol, 2017, 51(6): 1705-1721.
[7] 朱紫馨. 长链非编码RNA与肝纤维化关系的现况[J]. 贵州医药, 2017, 41(10): 1083-1085.
[8] Yu F, Zheng J, Mao Y, et al. Long non-coding RNA APTR promotes the activation of hepatic stellate cells and the progression of liver fibrosis[J]. Biochem Biophys Res Commun, 2015, 463(4): 679-685.
[9] Cao J, Han X, Qi X, et al. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p[J]. Int J Oncol, 2017, 51(4): 1115-1123.
[10] 谢军, 邹晨, 范钰, 等. 下调长链非编码RNA TUG1表达对骨肉瘤细胞迁移和侵袭的影响[J]. 中华实验外科杂志, 2017, 34(3): 449-451.
[11] Chen J, Jia YS, Liu GZ, et al. Role of LncRNA TUG1 in intervertebral disc degeneration and nucleus pulposus cells via regulating Wnt/β-catenin signaling pathway[J]. Biochem Biophys Res Commun, 2017, 491(3): 668-674.
[12] 范钰, 蒋孟林, 卫菲菲, 等. 小干扰RNA下调长链非编码RNA TUG1表达对人胃癌细胞迁移和侵袭的影响[J]. 中华实验外科杂志, 2016, 33(8): 1974-1976.
[13] Liu H, Zhou G, Fu X, et al. Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX[J]. Oncotarget, 2017, 8(60): 101899-101910.
[14] 王彬, 满韦韬, 常永凯, 等. TUG1基因沉默对脑胶质瘤生物学功能影响的实验研究[J]. 中华神经外科杂志, 2016, 32(9): 940-945.
[15] Li J, Zhang Q, Fan X, et al. The long noncoding RNA TUG1 acts as a competing endogenous RNA to regulate the Hedgehog pathway by targeting miR-132 in hepatocellular carcinoma[J]. Oncotarget, 2017, 8(39): 65932-65945.
[16] Wang X, Lopategi A, GeX, et al. Osteopontin induces ductular reaction contributing to liver fibrosis[J]. Gut, 2014, 63(11): 1805-1818.
[17] Qian H, Shi J, Fan TT, et al. Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats[J]. World J Gastroenterol, 2014, 20(7): 1822-1832.
[18] Lin YL, Lin HW, Chen YC, et al. Hepatoprotective effects of naturally fermented noni juice against thioacetamide-induced liver fibrosis in rats[J]. J Chin Med Assoc, 2017, 80(4): 212-221.
[19] Omran D, Yosry A, DarweeshSK, et al. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naive chronic HCV patients[J]. Clin Exp Med, 2018, 18(1): 45-50.
[20] 陈建亮, 李书, 刘雨亭, 等. 微小RNA-30a在肝纤维化中的表达及其影响[J]. 中华实验外科杂志, 2016, 33(10): 2302-2305.
[21] Yang D, Li L, QianS, et al. Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway[J]. J Nat Med, 2018, 72(1): 145-154.
[22] Su KY, Hsieh CY, Chen YW, et al. Taiwanese green propolis and propolin G protect the liver from the pathogenesis of fibrosis via eliminating TGF-β-induced Smad2/3 phosphorylation[J]. J Agric Food Chem, 2014, 62(14): 3192-3201.
[23] Yang N, Dang S, Shi J, et al. Caffeic acid phenethyl ester attenuates liver fibrosis via inhibition of TGF-β1/Smad3 pathway and induction of autophagy pathway[J]. Biochem Biophys Res Commun, 2017, 486(1): 22-28.

牛磺酸上调基因1(TUG1)对肝纤维化的作用及其机制^*

Effects of TUG1 on hepatic fibrosis and its mechanism

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	汤娟, 柯洁, 付裕, 何晓伟, 李先伟. Ⅱ型肺泡上皮细胞间质转分化中的Notch-1/ Twist-1信号通路机制^*[J]. 中国应用生理学杂志, 2021, 37(6): 577-583.
[2]	齐书妍, 黄华, 李永坤, 裴林国, 张文娟. 莪术醇对非酒精性脂肪性肝大鼠肝功能和肝纤维化的影响及机制^*[J]. 中国应用生理学杂志, 2021, 37(6): 611-615.
[3]	吴江立, 王晓影, 代成, 李睿嘉, 张越, 孙佳欢, 李爱英. 归脾汤对大鼠心肌缺血的干预作用^*[J]. 中国应用生理学杂志, 2021, 37(6): 694-698.
[4]	涂容芳, 何振华, 谭小武, 陈哲, 曾赛丽, 刘莎, 贾远航, 李雪花. 辛伐他汀对大鼠肺纤维化及其内皮间质变过程的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 454-459.
[5]	黄燕云, 高洁, 张利娜, 杜相欣, 张雨彤, 郭霞, 郝娜, 李建国, 张宇. 利用全细胞膜片钳技术记录大鼠脑片NMDA电流的研究^*[J]. 中国应用生理学杂志, 2021, 37(5): 459-462.
[6]	丁茂鹏, 韦凌霞, 王志旺, 程小丽, 庞亚蓉. 鳖甲育肝颗粒对复合因素所致肝纤维化大鼠TGF-β1/Smads通路的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 463-467.
[7]	吴经纬, 王一蓉, 陈伟, 刘文锋. 不同训练方式对大鼠骨骼肌纤维类型转化和CaMK II/MEF2传导途径的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 470-474.
[8]	许骥, 方以群, 包晓辰, 袁恒荣, 王楠, 王芳芳. 核辐射对大深度快速上浮脱险致减压病大鼠相关指标的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 486-489.
[9]	张瑜, 路青华, 曹海芳, 张生荣, 王虎德. GPR81激动剂对非酒精性脂肪肝病大鼠胰岛素抵抗的影响[J]. 中国应用生理学杂志, 2021, 37(4): 354-358.
[10]	丁海丽, 黄增浩, 任在方, 孙竹昕, 李俊平, 王瑞元. 针刺对大鼠运动性骨骼肌损伤内质网应激的干预作用及机制[J]. 中国应用生理学杂志, 2021, 37(4): 359-364.
[11]	郝礼森, 季景秀, 蒋美钰, 张明婷, 张晓岚, 展宗媛, 杨小师, 陈盼盼. RNA干扰下调PTEN表达对体外活化肝星状细胞α-微管蛋白及γ-微管蛋白表达的影响[J]. 中国应用生理学杂志, 2021, 37(4): 376-379.
[12]	杨向君, 王羽, E.巴雅日玛, 赵明, S.贺希格扎日嘎拉. 蒙药绍沙-7味丸防治大鼠心肌缺血/再灌注损伤的作用[J]. 中国应用生理学杂志, 2021, 37(4): 380-384.
[13]	郝卯林, 楼国强, 刘秀洁, 钱巍, 王嘉, 周卓琳, 王万铁. 细胞自噬在大鼠缺血/再灌注肺损伤中的调控作用[J]. 中国应用生理学杂志, 2021, 37(4): 385-388.
[14]	刘雪枫, 乔婧, 高建德, 陈正君, 刘雄. 党参总皂苷对TNBS诱导的大鼠溃疡性结肠炎的保护作用及其机制[J]. 中国应用生理学杂志, 2021, 37(4): 397-401.
[15]	耿元文, 林琴琴, 王湘怡, 李若明, 田振军. 间歇运动对心梗大鼠心肌氧化应激和炎症的影响及其机制[J]. 中国应用生理学杂志, 2021, 37(4): 439-444.